GSEA analysis demonstrated significant activation of glioma‐infiltrated macrophages/microglia (GIM) and PD‐L1 signaling pathways in the high‐risk group (Figure 5E,F), suggesting an inhibitory immune microenvironment. The gene discussed is CD274; the disease is central nervous system cancer.